Delcath Systems (DCTH) Income from Continuing Operations (2011 - 2026)
Delcath Systems (DCTH) posted quarterly Income from Continuing Operations of 1108000.0 for Q1 2026, down 203.65% year-over-year from 1069000.0 in Q1 2025, and up 41.56% quarter-over-quarter from 1896000.0 in Q4 2025.
Delcath Systems (DCTH) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Delcath Systems' Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 1108000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 203.65% year-over-year to 1108000.0; the TTM figure through Mar 2026 stood at 523000.0 (up 103.68% YoY), while the FY2025 annual figure was 2700000.0, up 110.23% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1108000.0, up from 1896000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2697000.0 in Q2 2025, with the low at 83406000.0 in Q3 2023.
- The 5-year median for Income from Continuing Operations is 8391000.0 (2022), against an average of 10197352.94.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations sank 917.52% in 2023, then soared 119.63% in 2025.
- Delcath Systems' Income from Continuing Operations stood at 8391000.0 in 2022, then plunged by 38.73% to 11641000.0 in 2023, then soared by 70.81% to 3398000.0 in 2024, then jumped by 44.2% to 1896000.0 in 2025, then jumped by 41.56% to 1108000.0 in 2026.
- Business Quant data shows DCTH's Income from Continuing Operations at 1108000.0 in Q1 2026, 1896000.0 in Q4 2025, and 830000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Delcath Systems | 603.74 Mn | 507.82 Mn | 26.15 Mn | 2.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.67 Mn |
| Mar 31, 2026 | -1.11 Mn |
| Dec 31, 2025 | -1.90 Mn |
| Sep 30, 2025 | 830,000.00 |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | -3.40 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | -13.74 Mn |
| Mar 31, 2024 | -11.11 Mn |
| Dec 31, 2023 | -11.64 Mn |
| Sep 30, 2023 | -83.41 Mn |
| Jun 30, 2023 | -8.99 Mn |
| Mar 31, 2023 | -9.26 Mn |
| Dec 31, 2022 | -8.39 Mn |
| Sep 30, 2022 | -8.20 Mn |
| Jun 30, 2022 | -9.92 Mn |
| Mar 31, 2022 | -8.75 Mn |
| Dec 31, 2021 | -5.08 Mn |
| Sep 30, 2021 | -7.49 Mn |